A New Lyme Disease Vaccine Is Showing Promise – IFL Science

Promising results have come out of the only active clinical trial for a vaccine against Lyme disease. Valneva, a French biotech company, recently announced its first Phase 2 clinical trial has shown that its vaccine against Lyme disease is both safe and effective.

The vaccine works by triggering the body’s immune system to produce antibodies for the six common serotypes of the disease that are found in North America and Europe. It does this by introducing an isolated protein of the pathogen to the body, allowing the immune system to recognize and respond to the surface proteins found on the bacteria responsible for Lyme disease, Borrelia burgdorferi.

Click here to read full article https://www.iflscience.com/health-and-medicine/a-new-lyme-disease-vaccine-is-showing-promise/

Font Resize